KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Current Deferred Revenue (2018 - 2025)

ClearPoint Neuro's Current Deferred Revenue history spans 13 years, with the latest figure at $2.5 million for Q3 2025.

  • For Q3 2025, Current Deferred Revenue rose 98.72% year-over-year to $2.5 million; the TTM value through Sep 2025 reached $2.5 million, up 98.72%, while the annual FY2024 figure was $2.1 million, 18.83% down from the prior year.
  • Current Deferred Revenue for Q3 2025 was $2.5 million at ClearPoint Neuro, up from $2.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $2.6 million in Q4 2023 and bottomed at $368000.0 in Q2 2021.
  • The 5-year median for Current Deferred Revenue is $1.1 million (2024), against an average of $1.2 million.
  • The largest annual shift saw Current Deferred Revenue plummeted 42.71% in 2021 before it soared 145.12% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $678000.0 in 2021, then surged by 57.23% to $1.1 million in 2022, then skyrocketed by 145.12% to $2.6 million in 2023, then dropped by 18.83% to $2.1 million in 2024, then rose by 17.3% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Current Deferred Revenue are $2.5 million (Q3 2025), $2.0 million (Q2 2025), and $1.6 million (Q1 2025).